Top Vaccines companies in Switzerland by Price to Earnings Ratio (P/E)
Switzerland
# |
Name |
Price to Earnings Ratio (P/E) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
275.21 |
Feb. 5, 2025 | USD 48.28 | 3.35% |
|
Switzerland |
|
| 2 |
44.02 |
Feb. 5, 2025 | USD 45.08 | 2.29% |
|
Switzerland |
|
| 3 |
-2.50 |
Feb. 5, 2025 | USD 4.99 | 1.08% |
|
Switzerland |
|
| 4 |
-15.37 |
Feb. 5, 2025 | USD 26.45 | -1.05% |
|
Switzerland |
Frequently Asked Questions
-
Which Vaccines company in Switzerland has the highest Price to Earnings Ratio (P/E) ?
The Vaccines company in Switzerland with the highest Price to Earnings Ratio (P/E) is Sandoz Group AG (Swiss Stock Exchange: SDZ.SW) at 275.21.
-
Which Vaccines company in Switzerland has the lowest Price to Earnings Ratio (P/E) ?
The Vaccines company in Switzerland with the lowest Price to Earnings Ratio (P/E) is PolyPeptide Group AG (Swiss Stock Exchange: PPGN.SW) at -15.37.
-
What are the top 10 Vaccines companies in Switzerland by Price to Earnings Ratio (P/E) ?
The top 10 Vaccines companies in Switzerland by Price to Earnings Ratio (P/E) are Sandoz Group AG, Basilea Pharmaceutica AG, Molecular Partners AG and PolyPeptide Group AG.
-
What are the bottom 10 Vaccines companies in Switzerland by Price to Earnings Ratio (P/E) ?
The bottom 10 Vaccines companies in Switzerland by Price to Earnings Ratio (P/E) are PolyPeptide Group AG, Molecular Partners AG, Basilea Pharmaceutica AG and Sandoz Group AG.
